Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Cancer Risks Linked to the Bad Luck Hypothesis and Epigenomic Mutational Signatures

Texto completo
Autor(es):
Belizario, Jose E.
Número total de Autores: 1
Tipo de documento: Artigo Científico
Fonte: EPIGENOMES; v. 2, n. 3 SEP 2018.
Citações Web of Science: 0
Resumo

Exposure to pathogen infection, and occupational and environmental agents, contributes to induction of most types of cancer through different mechanisms. Cancer is defined and characterized by accumulation of mutations and epimutations that lead to changes in the cellular genome and epigenome. According to a recent Bad Luck Hypothesis, random error mutations during DNA replication in a small population of stem cells may be implicated in two-thirds of variation of cancer risk in 25 organs and tissues. What determines stem cell vulnerability and risk of malignancy across the spectrum of organs, such as the brain, bone marrow, skeletal muscles, skin, and liver? Have stem cells pooled in particular tissues or organs evolved some critical ability to deal with DNA damage in the presence of extrinsic environmental factors? This paper describes how the complex replication and repair DNA systems control mutational events. In addition, recent advances on cancer epigenomic signatures and epigenetic mechanisms are discussed, which will guide future investigation of the origin of cancer initiating cells in tissue and organs in a clinical setting. (AU)

Processo FAPESP: 12/02497-7 - Análise da expressão de genes regulados pela proteína dermicidina nas células do melanoma maligno g-361 pelo método de dna-microarray
Beneficiário:Nancy Marcela Pérez Sosa
Modalidade de apoio: Bolsas no Brasil - Mestrado
Processo FAPESP: 14/20847-0 - Incorporação sítio específica de aminoácidos não naturais em proteínas: desenvolvimento de novas tecnologias de incorporação e aplicação no estudo de proteínas
Beneficiário:Vitor Marcelo Silveira Bueno Brandão de Oliveira
Modalidade de apoio: Auxílio à Pesquisa - Regular